Author(s): Rahul Vishvakarma, Arti Majumdar, Neelesh Malviya


DOI: 10.52711/0974-360X.2022.00540   

Address: Rahul Vishvakarma*, Arti Majumdar, Neelesh Malviya
Department of Pharmaceutics, Smriti College of Pharmaceutical Education, Indore - 452010 MP India.
*Corresponding Author

Published In:   Volume - 15,      Issue - 7,     Year - 2022

The motivation behind this investigation was to design novel drug delivery system containing orlistat micro sponges. Microsponges containing orlistat and Ethyl cellulose/ Eudragit RS 100 prepared by quasi emulsion solvent diffusion (Technique) method. The formulations were prepared step by step increases Drug: polymer ratio. The particle size (Malvern analyzer), Surface Morphology and structure examination (SEM) Production yield, Drug entrapment Efficiency and in vitro drug release studied of microsponges were examined. Shape or surface morphology and topography of the orlistat microsponges were examined by scanning electron microscopy. The drug orlistat disperse in GIT for better therapeutic effect as microsponges disperse freely in GIT. To improve absorption of orlistat so as to enhance bioavailability, micro sponges is used as delivery systems which show better absorption and bioavailability then other dosage form of orlistat. The particle size were prepared microsponges was observed in the range of 50.45 ± 0.85µm to 57.77 ± 1.35µm. The drug entrapment of the orlistat microsponges was observed in the range of 73.23 ± 0.23 to 83.41 ± 1.17 % The in vitro drug release study of the microsponges over 8 hour range from 59.28 ± 0.41% to 73.16 ± 0.89 %. The objective of this research work was to formulation and evaluation of orlistat loaded microsponges for management of obesity disease. Microsponges drug delivery system landscape have been highly and rapidly evolving. They are allowing for novel product form. Microsponges are safe biologically and extraordinary preferred position programmable release. This delivery system are being integrated to optimize the efficacy or free streaming effectiveness treatment.

Cite this article:
Rahul Vishvakarma, Arti Majumdar, Neelesh Malviya. Formulation and evaluation of orlistat loaded microsponges for the treatment of obesity. Research Journal of Pharmacy and Technology. 2022; 15(7):3221-5. doi: 10.52711/0974-360X.2022.00540

Rahul Vishvakarma, Arti Majumdar, Neelesh Malviya. Formulation and evaluation of orlistat loaded microsponges for the treatment of obesity. Research Journal of Pharmacy and Technology. 2022; 15(7):3221-5. doi: 10.52711/0974-360X.2022.00540   Available on:

1.    Morales P. Fujio S. Navarrete P. et al. Impact of dietary lipids on colonic function and microbiota: an experimental approach involving orlistat-induced fat malabsorption in human volunteers. Clin Transl Gastroenterol. 2016; 7(4):e161.  doi: 10.1038/ctg.2016.20
2.    Pozza C. Isidori AM. What’s Behind the Obesity Epidemic Imaging in Bariatric Surgery. New York: Springer International Publishing AG; 2018. pp. 1–8. doi: 10.1007/978-3-319-49299-5_1
3.    Aung K. Lorenzo C. Hinojosa MA. Haffner SM. Risk of developing diabetes and cardiovascular disease in metabolically unhealthy normal-weight and metabolically healthy obese individuals. J Clin Endocrinol Metab. 2014; 99(2):462–468.  doi:
4.    Kushner RF. Weight loss strategies for treatment of obesity. Prog Cardiovasc Dis. 2014; 56(4):465–472. doi:
5.    Dolenc A. Govedarica B. Dreu R. Kocbek P. Srcic S. Kristl J. Nanosized particles of orlistat with enhanced in vitro dissolution rate and lipase inhibition. Int J Pharm. 2010; 396(1–2):149–155. doi:
6.    Menendez JA. Vellon L. Lupu R. Antitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: blockade of cell cycle progression. promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene. Ann Oncol. 2005; 16(8):1253–1267. doi:
7.    Pandey HC. Radhakrishnan RB. Mohammed SF. Vaghela D. Narayana RGL. Inventis DDS PVT Ltd Pharmaceutical composition of orlistat. Application No 12/738 145 US Patent. 2010 doi:
8.    Lindenmüller IH. Lambrecht JT. Topical Applications and the Mucosa. Vol. 40. Basel: Karger Publishers; 2011. Oral care; pp. 107–115. doi:
9.    Gade MM. Hurkadale PJ. Formulation and evaluation of self-emulsifying orlistat tablet to enhance drug release and in vivo performance: factorial design approach. Drug Deliv Transl Res. 2016; 6(3):276–288. doi:
10.    Sangwai M. Sardar S. Vavia P. Nanoemulsified orlistat-embedded multi-unit pellet system (MUPS) with improved dissolution and pancreatic lipase inhibition. Pharm Dev Technol. 2014; 19(1):31–41. doi:
11.    Madhav KV. Kishan V. Self microemulsifying particles of loratadine for improved oral bioavailability: preparation. characterization and in vivo evaluation. J Pharm Investig. 2018; 48(4):497–508. doi:
12.    Kumar A. Sharma S. Kamble R. Self emulsifying drug delivery system (SEDDS): future aspects. Int J Pharm Pharm Sci. 2010; 2(4):7–13. doi:
13.    Narang AS. Delmarre D. Gao D. Stable drug encapsulation in micelles and microemulsions. Int J Pharm. 2007; 345(1–2):9–25. doi:
14.    Nazzal S. Khan MA. Controlled release of a self-emulsifying formulation from a tablet dosage form: stability assessment and optimization of some processing parameters. Int J Pharm. 2006; 315(1–2):110–121. doi:
15.    Ahsan MN. Verma PRP. Enhancement of in vitro dissolution and pharmacodynamic potential of olanzapine using solid SNEDDS. J Pharm Investig. 2018; 48(3):269–278. doi:

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

56th percentile
Powered by  Scopus

SCImago Journal & Country Rank

Recent Articles


Not Available